Reid G. Meyer

1.6k total citations
37 papers, 981 citations indexed

About

Reid G. Meyer is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Reid G. Meyer has authored 37 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Reid G. Meyer's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and HER2/EGFR in Cancer Research (7 papers). Reid G. Meyer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers) and HER2/EGFR in Cancer Research (7 papers). Reid G. Meyer collaborates with scholars based in United States, Belgium and Netherlands. Reid G. Meyer's co-authors include Robert B. Jenkins, Kevin C. Halling, И. А. Соколова, Walter King, Steven Seelig, Gordon W. Dewald, Rhett P. Ketterling, Thomas J. Sebo, Sanjay Ramakumar and John C. Cheville and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Urology.

In The Last Decade

Reid G. Meyer

36 papers receiving 953 citations

Peers

Reid G. Meyer
Pia Klausen Denmark
James L. Reading United Kingdom
P. Klemi Finland
Diana O. Treaba United States
Jeffrey M. Venstrom United States
Noah A. Brown United States
Serge Smeets Netherlands
Luis E. De Las Casas United States
Pia Klausen Denmark
Reid G. Meyer
Citations per year, relative to Reid G. Meyer Reid G. Meyer (= 1×) peers Pia Klausen

Countries citing papers authored by Reid G. Meyer

Since Specialization
Citations

This map shows the geographic impact of Reid G. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reid G. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reid G. Meyer more than expected).

Fields of papers citing papers by Reid G. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reid G. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reid G. Meyer. The network helps show where Reid G. Meyer may publish in the future.

Co-authorship network of co-authors of Reid G. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Reid G. Meyer. A scholar is included among the top collaborators of Reid G. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reid G. Meyer. Reid G. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pitel, Beth A., Saba Alvand, Carlos Sosa, et al.. (2025). Evaluation of Atypical Fluorescence in Situ Hybridization Findings by RNA Sequencing. Journal of Molecular Diagnostics. 27(11). 1098–1114.
2.
Meyer, Reid G., Patricia T. Greipp, Nicole L. Hoppman, et al.. (2024). Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients. Journal of Hematopathology. 17(2). 51–61. 1 indexed citations
3.
Smadbeck, James B., George Vasmatzis, Horatiu Olteanu, et al.. (2022). Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literature. Annals of Diagnostic Pathology. 58. 151942–151942. 1 indexed citations
4.
Geiersbach, Katherine B., Reid G. Meyer, Grant M. Spears, et al.. (2021). Detailed Reanalysis of 500 Breast Cancers With Equivocal HER2 Immunohistochemistry and Borderline ERBB2 Fluorescence In Situ Hybridization Results. American Journal of Clinical Pathology. 156(5). 886–894. 1 indexed citations
5.
Smadbeck, James B., Neeraj Sharma, Reid G. Meyer, et al.. (2021). Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma. Genes Chromosomes and Cancer. 60(10). 678–686. 5 indexed citations
6.
Pophali, Priyanka A., Rhett P. Ketterling, Reid G. Meyer, et al.. (2020). High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?. Blood Cancer Journal. 10(1). 5–5. 15 indexed citations
7.
Geiersbach, Katherine B., Reid G. Meyer, William R. Sukov, et al.. (2020). HER2 Testing for Breast Cancer in the Genomics Laboratory: A Sea Change for Fluorescence In Situ Hybridization. Archives of Pathology & Laboratory Medicine. 145(7). 883–886. 3 indexed citations
8.
Peterson, Jess F., Reid G. Meyer, Stephanie A. Smoley, et al.. (2019). Whole Genome Mate-pair Sequencing of Plasma Cell Neoplasm as a Novel Diagnostic Strategy: A Case of Unrecognized t(2;11) Structural Variation. Clinical Lymphoma Myeloma & Leukemia. 19(9). 598–602. 2 indexed citations
9.
Zhang, Dongwei, Xiaoyan Liao, Reid G. Meyer, et al.. (2019). Warthin-like Mucoepidermoid Carcinoma of the Parotid Gland: Unusual Morphology and Diagnostic Pitfalls. Anticancer Research. 39(6). 3213–3217. 16 indexed citations
10.
Meyer, Reid G. & Daniel L. Van Dyke. (2018). Analysis of Common Abnormalities Seen in Chronic Lymphocytic Leukemia Using Fluorescence In Situ Hybridization. Methods in molecular biology. 1881. 35–49. 1 indexed citations
11.
Haskell, Gloria, Yajuan J. Liu, Hui Chen, et al.. (2017). Integrated Analysis of HER2 Copy Number by Cytogenomic Microarray in Breast Cancers With Nonclassical In Situ Hybridization Results. American Journal of Clinical Pathology. 149(2). 135–147. 4 indexed citations
13.
Zreik, Riyam, et al.. (2015). A Rare Pediatric Example of Subcutaneous Extraskeletal Osteosarcoma. American Journal of Dermatopathology. 38(4). e44–e48. 6 indexed citations
14.
Perez, Edith A., Michael F. Press, Amylou C. Dueck, et al.. (2013). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Breast Cancer Research and Treatment. 138(1). 99–108. 63 indexed citations
15.
Ensenauer, Regina, Syed M. Jalal, Reid G. Meyer, & Dusica Babovic‐Vuksanovic. (2003). Unbalanced cryptic 5p deletion/17p duplication identified by subtelomeric FISH in a family with a boy with chimerism and a balanced t(4;5). American Journal of Medical Genetics Part A. 125A(1). 86–91. 4 indexed citations
16.
Jalal, Syed M., Gurbax S. Sekhon, Cindy Pham Lorentz, et al.. (2003). Utility of subtelomeric fluorescent DNA probes for detection of chromosome anomalies in 425 patients. Genetics in Medicine. 5(1). 28–34. 42 indexed citations
17.
Smoley, Stephanie A., Stephanie R. Brockman, Sarah F. Paternoster, Reid G. Meyer, & Gordon W. Dewald. (2003). A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia. Cancer Genetics and Cytogenetics. 148(1). 1–6. 15 indexed citations
19.
Tefferi, Ayalew, Reid G. Meyer, William A. Wyatt, & Gordon W. Dewald. (2001). Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia. British Journal of Haematology. 115(2). 316–319. 23 indexed citations
20.
Halling, Kevin C., Walter King, И. А. Соколова, et al.. (2000). A COMPARISON OF CYTOLOGY AND FLUORESCENCE IN SITU HYBRIDIZATION FOR THE DETECTION OF UROTHELIAL CARCINOMA. The Journal of Urology. 164(5). 1768–1775. 284 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026